KORU Medical Systems (NASDAQ:KRMD – Get Free Report) and Intuitive Surgical (NASDAQ:ISRG – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.
Profitability
This table compares KORU Medical Systems and Intuitive Surgical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KORU Medical Systems | -4.03% | -10.63% | -6.51% |
| Intuitive Surgical | 25.54% | 18.17% | 15.73% |
Institutional and Insider Ownership
58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 0.6% of Intuitive Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares KORU Medical Systems and Intuitive Surgical”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KORU Medical Systems | $41.13 million | 3.45 | -$2.64 million | ($0.04) | -77.25 |
| Intuitive Surgical | $11.58 billion | 13.56 | $2.86 billion | $8.27 | 54.75 |
Intuitive Surgical has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
KORU Medical Systems has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for KORU Medical Systems and Intuitive Surgical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KORU Medical Systems | 1 | 1 | 4 | 0 | 2.50 |
| Intuitive Surgical | 1 | 5 | 23 | 1 | 2.80 |
KORU Medical Systems currently has a consensus target price of $7.00, indicating a potential upside of 126.54%. Intuitive Surgical has a consensus target price of $493.54, indicating a potential upside of 9.00%. Given KORU Medical Systems’ higher possible upside, equities research analysts clearly believe KORU Medical Systems is more favorable than Intuitive Surgical.
Summary
Intuitive Surgical beats KORU Medical Systems on 13 of the 15 factors compared between the two stocks.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
About Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
